Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and postoperative ileus after cesarean section
ChiCTR2300068136Phase 4Not yet recruiting
- Sponsor
- Ruian People's Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative ileus (POI), pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Ruian People's Hospital. Primary endpoint: time to first flatus. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative ileus (POI)painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2300068136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068136.